IL6 and Alzheimer disease: First, knockdown of the P2Y1 receptor on astrocytes can alleviate overactivation in AD, reducing the overactivated astrocyte production of proinflammatory factors such as IL-6, that involves BBB damage [29] and the deposition of amyloid-beta in AD mouse brains, all of which relate to cognitive decline in AD mice.